Bambusa Therapeutics
Operator of a biotechnology company intended to create bispecific antibodies for treating immunological and inflammatory disorders. The company specializes in building a diverse portfolio of molecules...
Valuation
$555M
Latest known
Share Price
N/A
Total Raised
$143M
Last Round
N/A